Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review-Reference-Cited by-同舟云学术

Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review

Published:2019-11 Issue:11 Volume:20 Page:e619-e626
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Li Ning,Huang Hui-Yao,Wu Da-Wei,Yang Zhi-Min,Wang Jun,Wang Jian-Sheng,Wang Shu-Hang,Fang Hong,Yu Yue,Bai Ying,Yan Zhao,Cao Ye,Jiang Min,Liu Yan-Fei,Li Kun-Yan,Xu Bing-He,Sun Yan,He Jie

Publisher

Elsevier BV

Subject

Oncology

Reference20 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Challenges in anticancer drug R&D in China;Zhao;Lancet Oncol,2019

4. The changing landscape of clinical trial and approval processes in China;Zhou;Nat Rev Clin Oncol,2017

5. Clinical trials and drug approvals continue to accelerate in China;Wang;Lancet Oncol,2017

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Questionnaire survey and analysis of drug clinical research implementation capabilities of breast cancer treatment departments in Chinese hospitals;The Breast;2024-10

2. Toward a comprehensive solution for treating solid tumors using T-cell receptor therapy: A review;European Journal of Cancer;2024-09

3. Analysis of Clinical Trials Using Anti-Tumor Traditional Chinese Medicine Monomers;Drug Design, Development and Therapy;2024-06

4. Unveiling quality of clinical trial in China: from concern to confirmation;Cancer Communications;2024-03-06

5. Dynamic Clinical Success Rates for Drugs in the 21st Century;2024-02-29